October 4, 2021
The US Food and Drug Administration (FDA) has approved brexucabtagene autoleucel (Tecartus) for the treatment of adult patients (18 years and older) with relapsed or refractory […]
September 29, 2021
Mirum Pharmaceuticals Inc said its drug became the first U.S. approved therapy for treating itching in patients with rare liver disorder Alagille syndrome (ALGS), and would be […]
September 27, 2021
The US Drug Enforcement Administration (DEA) has issued a public safety alert over an “alarming” increase in fake prescription pills laced with the synthetic opioid fentanyl […]
September 24, 2021
The US Food and Drug Administration (FDA) has approved evolocumab (Repatha, Amgen), a PCSK9 inhibitor, for use as add-on treatment to diet alone or with other […]
September 23, 2021
Editor’s Note: September 23, 8:20 pm // This story has been updated with additional information on the ACIP meeting and quotes from committee members. A panel of […]
September 23, 2021
Sepbember 24, 2021 — Editor’s note: This story has been updated to reflect the CDC director’s decision to add healthcare workers to the boosters list. The […]
September 22, 2021
The US Food and Drug Administration (FDA) has approved cabozantinib (Cabometyx) for the treatment of locally advanced or metastatic differentiated thyroid cancer (DTC) in adults and […]
September 22, 2021
The US Food and Drug Administration (FDA) has approved ruxolitinib (Jakafi) for treatment of chronic graft-versus-host disease (GVHD) in adults and in pediatric patients 12 years […]
September 22, 2021
The Food and Drug Administration today gave the nod to topical ruxolitinib cream for the treatment of non-immunocompromised patients with mild to moderate atopic dermatitis ages […]